Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06545253 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A New Diagnostic Paradigm for Retinitis Pigmentosa Secondary to USH2A Pathogenic Variants

StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 9, 2024 (before its estimated February 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Aim of the study is to perform a non-invasive multimodal retinal imaging investigation in a cohort of patients affected by USH2A retinitis pigmentosa (USH2A-RP), in order to develop a new diagnostic paradigm to categorize clinically relevant subgroups. All the procedures will be performed according to normal clinical practice. In addition, a novel quantitative profiling of serum microRNAs will be carried out in order to analyze the clinical importance of microRNA biomarkers in the clinical setting of the disease.
Trial Details
NCT Number NCT06545253
Lead Sponsor IRCCS Ospedale San Raffaele
Conditions
(from sponsor)		 USH2A Variant Retinitis Pigmentosa
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov